128
Participants
Start Date
April 30, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
September 30, 2027
Emactuzumab
Emactuzumab administered once every 2 weeks (q2w)
Placebo
Matching placebo administered once every 2 weeks (q2w)
Taipei Veterans General Hospital, Taipei
Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert
Inselspital - Universitätsspital Bern, Bern
Seoul National University Hospital, Seoul
Universitäts Kinderspital Beider Basel (UKBB), Basel
LKH-Universitätsklinikum Graz, Graz
Hospital de La Santa Creu i Sant Pau, Barcelona
UZ Gent - Department of Medical Oncology, Ghent
National Taiwan University Hospital, Taipei
Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo
MedStar Washington Hospital Center, Georgetown
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Duke Cancer Center, Durham
Hospital Clinico San Carlos, Madrid
Oncopole Claudius Regaud Oncologie Médicale, Toulouse
Institut Bergonie - PPDS, Bordeaux
IRCCS lstituto Ortopedico Rizzoli, Bologna
Hospital Universitario Virgen del Rocio - PPDS, Seville
The Ohio State University, Columbus
Institut de Cancerologie de Ouest - Saint Herblain, Saint-Herblain
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Hospital Universitario Fundacion Jimenez Diaz, Zaragoza
Hospital Universitario Miguel Servet, Zaragoza
University of Minnesota, Minneapolis
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello, Pisa
Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello, Pisa
UNICANCER - Centre Oscar Lambret, Lille
Nuovo Ospedale di Prato, Prato
University of Kansas Cancer Center (Overland Park) - USOR, Overland Park
Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes, Lyon
AP-HP - Hôpital Cochin - Port-Royal, site Cochin, Paris
Institut Curie - Hôpital de Paris, Paris
MD Anderson Cancer Center, Houston
Sarcoma Oncology Research Center, LLC, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo
NextGen Oncology, Beverly Hills
OHSU Knight Cancer Institute Hematology Oncology, Portland
Arthur J.E. Child Comprehensive Cancer Centre, Calgary
Princess Margaret Cancer Centre, Toronto
McGill University Health Centre (MUHC), Montreal
Centre Antoine Lacassagne, Nice
Fondazione Policlinico Universitario Campus Bio-Medico, Rome
Leids Universitair Medisch Centrum, Leiden
Skanes Universitetssjukhus Lund, Lund
St James's University Hospital, Leeds
University College Hospital, London
Churchill Hospital, Cancer Haematology Center, Oxford
SynOx Therapeutics Limited
INDUSTRY